National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Dabigatran etexilate (Pradaxa®) is indicated for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.

 Rapid Review

Commenced Completed Outcome
09/05/2014 13/06/2014 Full Pharmacoeconomic Evaluation Not Recommended